These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12499712)

  • 1. Complaints of poststroke insomnia and its treatment with mianserin.
    Palomäki H; Berg A; Meririnne E; Kaste M; Lönnqvist R; Lehtihalmes M; Lönnqvist J
    Cerebrovasc Dis; 2003; 15(1-2):56-62. PubMed ID: 12499712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.
    Palomäki H; Kaste M; Berg A; Lönnqvist R; Lönnqvist J; Lehtihalmes M; Hares J
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):490-4. PubMed ID: 10201422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia in ischemic stroke patients.
    Leppävuori A; Pohjasvaara T; Vataja R; Kaste M; Erkinjuntti T
    Cerebrovasc Dis; 2002; 14(2):90-7. PubMed ID: 12187012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poststroke depression: an 18-month follow-up.
    Berg A; Palomäki H; Lehtihalmes M; Lönnqvist J; Kaste M
    Stroke; 2003 Jan; 34(1):138-43. PubMed ID: 12511765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insomnia and health-related quality of life in stroke.
    Tang WK; Grace Lau C; Mok V; Ungvari GS; Wong KS
    Top Stroke Rehabil; 2015 Jun; 22(3):201-7. PubMed ID: 25908494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin].
    Brion S; Audrain S; de Bodinat C
    Presse Med; 1996 Mar; 25(9):461-8. PubMed ID: 8685201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
    Ivgy-May N; Ruwe F; Krystal A; Roth T
    Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
    Ivgy-May N; Roth T; Ruwe F; Walsh J
    Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of post stroke depression with social factors, insomnia, and neurological status in Chinese elderly population.
    Wang L; Tao Y; Chen Y; Wang H; Zhou H; Fu X
    Neurol Sci; 2016 Aug; 37(8):1305-10. PubMed ID: 27120072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study
.
    Glozier N; Moullaali TJ; Sivertsen B; Kim D; Mead G; Jan S; Li Q; Hackett ML
    Cerebrovasc Dis Extra; 2017; 7(1):9-20. PubMed ID: 28161702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Morokuma I; Katsuki F; Fujita H; Sasaki M; Kawamura C; Perlis ML
    J Clin Psychiatry; 2011 Dec; 72(12):1651-8. PubMed ID: 21457679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of trazodone and mianserin for patients with late-life chronic schizophrenia and tardive dyskinesia: an add-on, double-blind, placebo-controlled study.
    Hayashi T; Yokota N; Takahashi T; Tawara Y; Nishikawa T; Yano T; Furutani M; Fujikawa T; Horiguchi J; Yamawaki S
    Int Clin Psychopharmacol; 1997 Jul; 12(4):199-205. PubMed ID: 9347380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multinational study of sleep disorders during female mid-life.
    Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
    Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.